These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30477891)

  • 1. Evaluation of neomycin analogues for HIV-1 RRE RNA recognition identifies enhanced activity simplified neamine analogues.
    Simon B; Walmsley C; Jackson VJ; Garvey EP; Slater MJ; Berrisford DJ; Gardiner JM
    Bioorg Med Chem Lett; 2019 Jan; 29(2):339-341. PubMed ID: 30477891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of neomycin, paromomycin, and neamine-arginine conjugates, targeting HIV-1 gp120-CXCR4 binding step.
    Borkow G; Vijayabaskar V; Lara HH; Kalinkovich A; Lapidot A
    Antiviral Res; 2003 Nov; 60(3):181-92. PubMed ID: 14638394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of biomimetic analogs of neomycin B: potential inhibitors of the HIV RNA Rev response element.
    Nishizono N; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):283-95. PubMed ID: 10772716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of a neamine dimer targeting the dimerization initiation site of HIV-1 RNA.
    Bodlenner A; Alix A; Weibel JM; Pale P; Ennifar E; Paillart JC; Walter P; Marquet R; Dumas P
    Org Lett; 2007 Oct; 9(22):4415-8. PubMed ID: 17915882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of dimeric aminoglycosides to the HIV-1 rev responsive element (RRE) RNA construct.
    Tok JB; Dunn LJ; Des Jean RC
    Bioorg Med Chem Lett; 2001 May; 11(9):1127-31. PubMed ID: 11354359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide nucleic acid-neamine conjugate that targets and cleaves HIV-1 TAR RNA inhibits viral replication.
    Riguet E; Tripathi S; Chaubey B; Désiré J; Pandey VN; Décout JL
    J Med Chem; 2004 Sep; 47(20):4806-9. PubMed ID: 15369382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of novel neamine derivatives effectively targeting to RNA.
    Xu Y; Jin H; Yang Z; Zhang L; Wang Q; Li M; Zhang L
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2103-6. PubMed ID: 19327991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neamine dimers targeting the HIV-1 TAR RNA.
    Riguet E; Désiré J; Boden O; Ludwig V; Göbel M; Bailly C; Décout JL
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4651-5. PubMed ID: 16153833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neamine derivatives having a nucleobase with a lysine or an arginine as a linker, their synthesis and evaluation as potential inhibitors for HIV TAR-Tat.
    Yajima S; Shionoya H; Akagi T; Hamasaki K
    Bioorg Med Chem; 2006 Apr; 14(8):2799-809. PubMed ID: 16413787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1.
    Inoue R; Watanabe K; Katou T; Ikezawa Y; Hamasaki K
    Bioorg Med Chem; 2015 May; 23(9):2139-47. PubMed ID: 25819332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
    Luedtke NW; Liu Q; Tor Y
    Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailable inhibitors of HIV-1 RNA biogenesis identified through a Rev-based screen.
    Prado S; Beltrán M; Coiras M; Bedoya LM; Alcamí J; Gallego J
    Biochem Pharmacol; 2016 May; 107():14-28. PubMed ID: 26896646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
    Hamasaki K; Ueno A
    Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of peptides with nucleobase amino acids: design and synthesis of the nucleobase-conjugated peptides derived from HIV-1 Rev and their binding properties to HIV-1 RRE RNA.
    Takahashi T; Hamasaki K; Ueno A; Mihara H
    Bioorg Med Chem; 2001 Apr; 9(4):991-1000. PubMed ID: 11354682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of biomimetic analogs of neomycin B].
    Nishizono N
    Yakugaku Zasshi; 2002 Jul; 122(7):465-9. PubMed ID: 12136642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition.
    Werstuck G; Zapp ML; Green MR
    Chem Biol; 1996 Feb; 3(2):129-37. PubMed ID: 8807838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
    Lacourciere KA; Stivers JT; Marino JP
    Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neamine and 2-deoxystreptamine neomycin derivatives exhibit antinociceptive activity in rat models of phasic, incision and neuropathic pain.
    Prado WA; Rossaneis AC; Carvalho I; Zamoner LO; Corrado AP
    J Pharm Pharmacol; 2015 Dec; 67(12):1696-704. PubMed ID: 26376780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
    Sugaya M; Nishino N; Katoh A; Harada K
    J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neomycin B-arginine conjugate, a novel HIV-1 Tat antagonist: synthesis and anti-HIV activities.
    Litovchick A; Lapidot A; Eisenstein M; Kalinkovich A; Borkow G
    Biochemistry; 2001 Dec; 40(51):15612-23. PubMed ID: 11747436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.